Home

Investor Relations

Company Profile

Corporate Governance

Stock Information

Analysts Coverage

Email Alerts

Press Room

Press Releases

Presentations & Recent Events

Request Materials

EnteroMedics FAQ

Abstracts and Articles

Contact Information

Annual Report and Proxy

SEC Filings

Investor FAQs

Shareholder Briefcase

 

 

Abstracts and Articles



2009

Selection of Electrical Algorithms to Treat Obesity with Intermittent Vagal Block Using An Implantable Medical Device

Authors: Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG.

Surgery for Obesity and Related Diseases 2009;5:224-230


Intermittent Vagal Blocking with an Implantable Device Reduces Maximum Tolerated Volume (MTV) During a Standardized Nutrient Drink Test in Obese Subjects.

Authors: Herrera MF, Burton D, Pantoja JP, Sanchez-Leenheer S, Bachmann B, Valdovinos M, Bhole D, Prindle S, Tweden KS, Vollmer MC, Wilson RR, Camilleri M.

Gastroenterology 2009;136:A386

Presented, Annual Meeting, Digestive Disease Week, Chicago, IL, 30 May – 4 June 2009).


Correlations Between Enhanced Satiety and Reduced Calorie Intake During Intermittent Vagal Block (VBLOC Therapy) to Treat Obesity.

Authors: Billington CJ, Kow L, Collins J, Wray N, Tweden KS, Vollmer MC, Wilson RR, Yurik TM, Freston JW, Toouli J.

Gastroenterology 2009;136:A386

Presented at Annual Meeting, Digestive Disease Week, Chicago, IL, 30 May – 4 June 2009).


Intermittent Vagal Blockade with an Implantable Device Improves Blood Pressure in Obese Subjects

Authors: Toouli J, Brancatisano R, Keller U, Kulseng B, Brancatisano A, Frey DM, Kow L, Johnsen G, Bhole D, Billington CJ, Tweden KS, Wilson RR, Carey RM.

Surgery for Obesity and Related Diseases 2009;5:S51-S52

Presented, Annual Meeting, American Society for Metabolic and Bariatric Surgery, Dallas, TX, 21 – 26, June 2009


Intermittent Vagal Blockade with an Implantable Device Improves Glycemic Control in Obese Subjects with Type 2 Diabetes Mellitus

Authors: Herrera MF, Brancatisano R, Keller U, Kulseng B, Toouli J, Brancatisano A, Frey DM, Kow L, Johnsen G, Pantoja JP, Bhole D, Carey RM, Tweden KS, Wilson RR, Billington CJ.

Surgery for Obesity and Related Diseases 2009;5:S48-S49

Presented, Annual Meeting, American Society for Metabolic and Bariatric Surgery, Dallas, TX, 21-26, June 2009).


Intermittent Vagal Blocking with an Implantable Device Reduces Maximum Tolerated Volume (MTV) During a Standardized Nutrient Drink Test in Obese Subjects

Herrera MF, Burton D, Pantoja JP, Leenheer S, Bachmann B, Valdovinos M, Knudson M, Tweden KS Wilson RR, Camilleri M.

Obesity Surgery 2009;19:1012

Presented, Annual Meeting, International Federation for the Surgery of Obesity, Paris, France, 26-29 August, 2009).


VBLOC and Improvements in Co-Morbidities in Obese Subjects During Weight Loss

Authors: Herrera MF, Kow L, Pantoja JP, Knudson M, Tweden KS, Wilson RR, Yurik T, Toouli J.

Obesity Surgery 2009;19:983-984

Presented, Annual Meeting, International Federation for the Surgery of Obesity, Paris, France, 26-29 August, 2009).


2008

Comparison of Food Ingestion Disorders with Three Devices for Obesity Treatment

Authors: Kow L, Toouli J, Freston JW, Tweden KS, Wilson RR, Moody FG

Obesity 2008;16:S222

Presented, The Obesity Society Annual Meeting, Phoenix, AZ, 3-7 October 2008


Intra-abdominal Vagal Blocking Reduces Body Weight with Associated Reductions in Heart Rate and Without Adverse Effect on Electrocardiographic Parameters

Authors: Wilson RR, Toouli J, Kow L, Keller U, Frey DM, Kulseng B, Johnsen G, Marvik R, Tweden KS, Freston JW, Pritchett ELC, Billington CJ.

Obesity 2008;16:S222

Presented, The Obesity Society Annual Meeting, Phoenix, AZ, 3-7 October 2008


An Implantable Vagal Blocking System To Treat Obesity: Laparoscopic Implantation Technique And Early Results In A Proof-Of-Principle Clinical Study

Authors: L Kow, CJ Billington, ML Kendrick, MG Sarr, MD Bierk, KS Tweden, RR Wilson. and J Toouli

Surgical Endoscopy 2008:SAGES 2008 Emerging Technology Oral Abstracts

Presented, Society of American Gastrointestinal and Endoscopic Surgeons/SAGES Annual Meeting, Philadelphia, PA, April 2008


Vagal Blocking for Obesity Control (VBLOC™): Interim Six Month Results in an Ongoing Trial Using a Second Generation System

Authors: Toouli MD, B Kulseng MD, U Keller MD, L Kow MD, R. Marvik MD, G. Johnsen MD, D M Frey MD, K S Tweden PhD, R.R. Wilson MD, C J Billington MD, Flinders Medical Centre Norway; University Hospital, Basel, Switzerland; EnteroMedics Inc., St. Paul, MN, US; University of Minnesota, Minneapolis, MN, USA

Surgical Endoscopy 2008 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons Philadelphia, Pennsylvania, USA, April 2008

Presented, Society of American Gastrointestinal and Endoscopic Surgeons/SAGES Annual Meeting, Philadelphia, PA, April 2008


Intra-Abdominal Vagal Blocking Reduces Calorie Intake, Enhances Satiation and Reduces Hunger During Significant and Sustained Weight Loss in Obese Subjects

Authors: James Toouli, Lilian Kow, Jane Collins, Nicholas H. Wray, Katherine S. Tweden, Mark C. Vollmer, Richard R. Wilson, James W Freston, Charles J. Billington

Gastroenterology 2008;134(Suppl 1):A370.

Presented at Annual Meeting, American Gastroenterology Association/Digestive Diseases Week, San Diego, CA, May 2008


Vagal Blocking for Obesity Control (VBLOC™): Ongoing Comparison of Weight Loss with Two Generations of an Active, Implantable Device

Authors: James Toouli, PhD, Baard Kulseng, MD, PHD; Ulrich Keller; Lilian Kow, MD, PhD; Ronald Marvik, MD, PhD; Gjermund Johnsen; Daniel M. Frey, M.D; Katherine S. Tweden, PhD; Richard R. Wilson, M0; Charles J. Billington, MD; Frank G. Moody, MD;

Surgery for Obesity and Related Diseases 2008;4:305

Presented at Annual Meeting, American Society for Metabolic and Bariatric Surgery, Washington, DC, 15-20 June 2008


Intra-abdominal vagal blocking (VBLOC therapy): Clinical results with a new implantable medical device

Authors: M. Camilleri, MD, J. Toouli, MD, PhD, M. F. Herrera, MD, B. Kulseng, MD, PhD, L. Kow, MD, PhD, J. P. Pantoja, MD, R. Marvik, MD, PhD, G. Johnsen, MD, C. J. Billington, MD, F. G. Moody, MD, M. B. Knudson, PhD, K. S. Tweden, PhD, M. Vollmer, BA, R. R. Wilson, MD, and M. Anvari, MD, PhD

Surgery: Journal of the Society of University Surgeons 2008;143:723-731.


Selecting Vagal Blocking Electrical Algorithms for Obesity Treatment

Authors: L Kow, M.F. Herrera, J.P Pantoja, K.S. Tweden, R.R. Wilson, C.J. Billington, J. Toouli

Obesity Surgery 2008;18:924

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008


Implantation Technique of a Rechargeable Vagal Blocking System for Treatment of Obesity

Authors: M.F. Herrera, J.P. Pantoja, D.M. Frey, K.S. Tweden, MD. Bierk

Obesity Surgery 2008;18:946

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008


Comparison of Food Ingestion Disorders with Three Devices for Obesity Treatment

Authors: L Kow, J. Toouli, J.W. Freston, K.S. Tweden, R.R. Wilson, F.G. Moody

Obesity Surgery 2008;18:914

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008

Obesity 2008;16:S222

Presented at Annual Meeting, The Obesity Society, Phoenix, AZ, 3-7 October 2008


Intra-Abdominal Vagal Blocking Reduces Body Weight with Associated Reductions in Heart Rate and Without Adverse Effects on Electrocardiographic Parameters

Authors: A.R. Wilson, J. Toouli, L. Kow, K.S. Tweden, J.W. Freston, E.L.C. Pritchett, C.J. Billington

Obesity 2008;16:S222

Presented at Annual Meeting, The Obesity Society, Phoenix, AZ, 3-7 October 2008

Obesity Surgery 2008;18:923

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008


Selection of Electrical Algorithms to Treat Obesity with Intermittent Vagal Block Using an Implantable Medical Device

Authors: Michael Camilleri, M.D., James Toouli, M.D., Ph.D., Miguel F. Herrera, M.D., Lilian Kow, M.D., Ph.D., Juan Pablo Pantoja, M.D., Charles J. Billington, M.D., Katherine S. Tweden, Ph.D., Richard R. Wilson, M.D., Frank G. Moody, M.D.

Surgery for Obesity and Related Diseases, Volume 5, Issue 2, Pages 224-229 (March 2009)


2007

Vagal Blocking for Obesity Control (VBLOC): An Open-label Study of an Implantable, Programmable Medical Device to Treat Obesity

Authors: Lilian Kow, MD, Miguel Herrera, MD, B. Kulseng , R. Marvik, MD, Juan Pablo Pantoja, MD, Mehran Anvari, MD, Michael Bierk ,MD, James Freston, MD, M. Knudson, PhD, Katherine Tweden, PhD, Mark Vollmer, Richard R. Wilson, MD, and James Toouli, MD

Obesity Surgery 2007;17:1043

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Porto, Portugal, September 2007


Vagal Blocking for Obesity Control (VBLOC): Effects on Excess Weight Loss, Calorie Intake, Satiation and Satiety

Authors: James Toouli, MD, Jane Collins, MD, Charles Billington, MD, Mark Knudson, PhD, Chris Pulling, MD, Katherine S. Tweden, PhD, Mark Vollmer, Richard R. Wilson, MD, and Lilian Kow, MD

Obesity Surgery 2007;17:1043

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Porto, Portugal, September 2007


Vagal Blocking for Obesity Control (VBLOC): Plasma Pancreatic Polypeptide (PPP) Response to a Standardized Sham Meal Challenge

Authors: Michael Camilleri, Miguel Herrera, Lilian Kow, Juan Pablo Pantoja, James Toouli, Charles Billington, James Preston, Mark Knudson, Mark Vollmer, Richard Wilson, Katherine Tweden

Obesity 2007;15:A6-A7

Presented at Annual Meeting, The Obesity Society/North American Association for the Study of Obesity, October 2007


Vagal Blocking for Obesity Control (VBLOC Therapy): Rechargeable and RF-coupled Technology Platforms

Authors: Mark B. Knudson, PhD, Adrianus Donders, MS, and Mark R. Stultz, MS, EnteroMedics Inc

Presented at Annual Meeting, Presented at Annual Meeting, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), 2007


2006

Vagal Blocking for Obesity Control (VBLOC): Concordance of Effects of Very High Frequency Vagal Blocking Currents at the Neural and Organ Levels Using Two Pre-clinical Models.

Authors: Tweden KS, Anvari M, Bierk MD, Billington CJ, Camilleri M, Honda CN, Knudson MB, Larson DE, Wilson RR, Freston JW.

Gastroenterology 2006;130 (Suppl 2):A-148

Presented at Annual Meeting, American Gastroenterology Association/Digestive Diseases Week, Los Angeles, CA, May 2006.


Vagal Blocking for Obesity Control (VBLOC): Studies of Pancreatic and Gastric Function and Safety in a Porcine Model.

Authors: Tweden KS, Sarr MG, Bierk MD, Camilleri M, Kendrick ML, Knudson MB, Moody FG, Wilson RR, Anvari M.

Surgery for Obesity and Related Diseases 2006;2:301

Presented at Annual Meeting, American Society for Bariatric Surgery, San Francisco, CA, June 2006


Vagal Blocking for Obesity Control (VBLOC): Studies of Pancreatic Function and Safety in a Porcine Model

Authors: Tweden KS, Toouli J, Kow L, Herrera M, Pantoja JP, Bierk MD, Knudson MB, Wilson RR, Anvari M.

Obesity Surgery 2006;16:988

Presented at Annual Meeting, International Federation for the Surgery of Obesity, Sydney, Australia, August 2006


Vagal Blocking for Obesity Control (VBLOC) Therapy: Pre-clinical Findings and Rationale Guiding the Development of the First Active Implantable System Designed to Neuroregulate Multiple Obesity Management Mechanisms

Authors: Mark B. Knudson, PhD, Richard R. Wilson, MD, Adrianus Donders, MS

Presented at Annual Meeting, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Dallas, Texas, April 2006


 

 

Home | What is VBLOC® Therapy? | Why VBLOC® Therapy?
Bariatric Weight Loss Surgery | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised May 2009.